Catalyst Wire Dossier Catalyst Wire Dossier

GSK2239633 FTIH

GSK2239633 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK2239633 FTIH, covering 2017-07-21 to 2017-07-21. Get the full timeline:

Most recent: Clinical Trial Update: GSK2239633 FTIH Study [Phase 1]

See pricing